Compare Wockhardt with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs PFIZER - Comparison Results

WOCKHARDT     Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT PFIZER WOCKHARDT/
PFIZER
 
P/E (TTM) x -22.8 33.3 - View Chart
P/BV x 1.2 5.6 21.6% View Chart
Dividend Yield % 0.0 0.6 0.5%  

Financials

 WOCKHARDT   PFIZER
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
PFIZER
Mar-18
WOCKHARDT/
PFIZER
5-Yr Chart
Click to enlarge
High Rs1,0122,365 42.8%   
Low Rs5321,625 32.7%   
Sales per share (Unadj.) Rs355.9430.3 82.7%  
Earnings per share (Unadj.) Rs-60.378.7 -76.6%  
Cash flow per share (Unadj.) Rs-46.893.2 -50.2%  
Dividends per share (Unadj.) Rs0.0120.00 0.1%  
Dividend yield (eoy) %01.0 0.1%  
Book value per share (Unadj.) Rs257.8586.5 44.0%  
Shares outstanding (eoy) m110.6345.75 241.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.24.6 46.8%   
Avg P/E ratio x-12.825.3 -50.5%  
P/CF ratio (eoy) x-16.521.4 -77.1%  
Price / Book Value ratio x3.03.4 88.0%  
Dividend payout %025.4 -0.1%   
Avg Mkt Cap Rs m85,37991,271 93.5%   
No. of employees `0006.32.6 237.8%   
Total wages/salary Rs m9,3713,143 298.2%   
Avg. sales/employee Rs Th6,295.07,484.8 84.1%   
Avg. wages/employee Rs Th1,498.31,195.0 125.4%   
Avg. net profit/employee Rs Th-1,066.31,369.1 -77.9%   
INCOME DATA
Net Sales Rs m39,36919,685 200.0%  
Other income Rs m1,2021,143 105.2%   
Total revenues Rs m40,57120,828 194.8%   
Gross profit Rs m185,003 0.4%  
Depreciation Rs m1,495663 225.7%   
Interest Rs m2,5554 60,831.0%   
Profit before tax Rs m-2,8305,479 -51.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m2571,878 13.7%   
Profit after tax Rs m-6,6693,601 -185.2%  
Gross profit margin %025.4 0.2%  
Effective tax rate %-9.134.3 -26.5%   
Net profit margin %-16.918.3 -92.6%  
BALANCE SHEET DATA
Current assets Rs m33,79624,167 139.8%   
Current liabilities Rs m26,9179,544 282.0%   
Net working cap to sales %17.574.3 23.5%  
Current ratio x1.32.5 49.6%  
Inventory Days Days7955 144.0%  
Debtors Days Days8929 310.9%  
Net fixed assets Rs m39,6649,514 416.9%   
Share capital Rs m553458 120.9%   
"Free" reserves Rs m27,96826,375 106.0%   
Net worth Rs m28,52226,832 106.3%   
Long term debt Rs m21,73125 86,924.4%   
Total assets Rs m81,62036,900 221.2%  
Interest coverage x-0.11,305.5 -0.0%   
Debt to equity ratio x0.80 81,775.3%  
Sales to assets ratio x0.50.5 90.4%   
Return on assets %-5.09.8 -51.6%  
Return on equity %-23.413.4 -174.2%  
Return on capital %-7.720.4 -37.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,80722 43,781.7%   
Fx outflow Rs m1,7891,489 120.1%   
Net fx Rs m8,019-1,466 -546.9%   
CASH FLOW
From Operations Rs m6843,318 20.6%  
From Investments Rs m6,302-2,383 -264.5%  
From Financial Activity Rs m-7,695-1,104 697.3%  
Net Cashflow Rs m-664-169 394.1%  

Share Holding

Indian Promoters % 74.5 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 2.3 7.5 30.7%  
FIIs % 7.7 4.9 157.1%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 23.7 65.0%  
Shareholders   67,757 85,207 79.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   STRIDES PHARMA SCIENCE  AJANTA PHARMA  ALEMBIC LTD  DR. DATSONS LABS  ELDER PHARMA  

Compare WOCKHARDT With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Extend Losses; Yes Bank & Tata Steel Top Losers(12:30 pm)

Share markets in India have extended early losses and are presently trading deep in the red. Despite the cool-off in global oil prices, benchmark indices struggled as foreign investors.

Related Views on News

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (3QFY19); Net Profit Down 80.6% (Quarterly Result Update)

Jan 29, 2019 | Updated on Jan 29, 2019

For the quarter ended December 2018, WOCKHARDT LTD. has posted a net profit of Rs 769 m (down 80.6% YoY). Sales on the other hand came in at Rs 10 bn (up 4.0% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Sep 19, 2019 12:21 PM

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WOCKHARDT - SANOFI INDIA COMPARISON

COMPARE WOCKHARDT WITH

MARKET STATS